Advertisement

Topics

"Astellas Reports First Quarter Financial Results FY2016 164KB" Drugs and Medication Database

00:24 EST 23rd February 2019 | BioPortfolio

Here are the most relevant "Astellas Reports First Quarter Financial Results FY2016 164KB" Drugs and Medications that we have found in our database.

More Information about "Astellas Reports First Quarter Financial Results FY2016 164KB" on BioPortfolio

We have published hundreds of Astellas Reports First Quarter Financial Results FY2016 164KB news stories on BioPortfolio along with dozens of Astellas Reports First Quarter Financial Results FY2016 164KB Clinical Trials and PubMed Articles about Astellas Reports First Quarter Financial Results FY2016 164KB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Astellas Reports First Quarter Financial Results FY2016 164KB Companies in our database. You can also find out about relevant Astellas Reports First Quarter Financial Results FY2016 164KB Drugs and Medications on this site too.

Showing "Astellas Reports First Quarter Financial Results FY2016 164KB" Drugs and Medications 1–25 of 27

Possibly Relevant

Denti-care [ar medicom inc]

Denti-Care Denti-Foam Topical Fluoride Foam Orange 1.23% Fluoride Ions

Denti-care [ar medicom inc]

Denti-Care Denti-Foam Topical Fluoride Foam grape 1.23% Fluoride Ions

Denti-care [ar medicom inc]

Denti-Care Denti-Foam Topical Fluoride Foam Bubble Gum 1.23% Fluoride Ions

Denti-care [ar medicom inc]

Denti-Care Denti-Foam Topical Fluoride Foam Raspberry 1.23 % Fluoride Ions

Denti-care [ar medicom inc]

Denti-Care Denti-Foam 1.76% Topical Sodium Fluoride Foam Strawberry

Denti-care denti-foam [amd medicom inc]

10037-RB Raspberry Foam DentiCare Pro-Foam 2.72 % Topical Sodium Fluoride

Myrbetriq [astellas pharma us, inc.]

These highlights do not include all the information needed to use MYRBETRIQ safely and effectively. See full prescribing information for MYRBETRIQ. MYRBETRIQ (mirabegron extended-release tablets) for oral use Initial U.S. Approval: 2012

Vesicare [astellas pharma us, inc.]

These highlights do not include all the information needed to use VESIcare safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tabletsInitial U.S. Approval: 2004

Vesicare [a-s medication solutions]

These highlights do not include all the information needed to use VESIcare safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tabletsInitial U.S. Approval: 2004

Vesicare [carilion materials management]

These highlights do not include all the information needed to use VESIcare safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tabletsInitial U.S. Approval: 2004

Vesicare [cardinal health]

These highlights do not include all the information needed to use VESIcare safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tabletsInitial U.S. Approval: 2004

Adenocard [astellas pharma us, inc.]

ADENOCARD  IV(adenosine injection)FOR RAPID BOLUS INTRAVENOUS USE

Xospata [astellas pharma us, inc.]

These highlights do not include all the information needed to use XOSPATA safely and effectively. See full prescribing information for XOSPATA. XOSPATA (gilteritinib) tablets, for oral useInitial U.S. Approval: 2018

Myrbetriq [cardinal health]

These highlights do not include all the information needed to use MYRBETRIQ safely and effectively. See full prescribing information for MYRBETRIQ.MYRBETRIQ (mirabegron) extended-release tablets, for oral useInitial U.S. Approval: 2012

Abilify mycite [otsuka america pharmaceutical, inc.]

These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Protopic [astellas pharma us inc.]

PROTOPIC(tacrolimus) Ointment 0.03% Ointment 0.1% FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC USE

Aripiprazole [preferred pharmaceuticals inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [major pharmaceuticals]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [torrent pharmaceuticals limited]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002



Advertisement
Quick Search
Advertisement
Advertisement